Tapewire

Nasdaq · USD

VRTX

VERTEX PHARMACEUTICALS INC / MA

Export transactions ↓
Tapewire entity
2875
SEC CIK
0000875320
Parsed reports
2,554

Last 12 months

Inside the activity.

0 purchase rows · 93 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202506
Dec 2025016
Jan 202602
Feb 2026049
Mar 202605
Apr 202601
May 202606
Jun 202605
Jul 202603
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 27, 2016 Filed Jan 29, 2016 21:08 UTC Exercise / conversionCommon Stock 11,200 $35.64 $399,168.00
Disclosure

SEC source: 0001209191-16-094138 · doc4.xml · nonDerivative · entry 1

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 276,484

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 20, 2016 Filed Jan 22, 2016 21:20 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 10,400 $0.00 Strike: $35.64 $0.00
Disclosure

SEC source: 0001209191-16-093116 · doc4.xml · derivative · entry 12

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,200

Underlying: Common Stock · 10,400 shares

Expires 2016-02-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F10 · derivative.exercise_date: Fully vested.

Read SEC document
January 20, 2016 Filed Jan 22, 2016 21:20 UTC SaleCommon Stock 100 $98.46 $9,846.00
Disclosure

SEC source: 0001209191-16-093116 · doc4.xml · nonDerivative · entry 9

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 265,284

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

Read SEC document
January 20, 2016 Filed Jan 22, 2016 21:20 UTC SaleCommon Stock 1,000 $97.46 $97,460.00
Disclosure

SEC source: 0001209191-16-093116 · doc4.xml · nonDerivative · entry 8

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 265,384

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F9 · price: Open market sales reported on this line occurred at a weighted average price of $97.46 (range $97.12 to $97.61).

Read SEC document
January 20, 2016 Filed Jan 22, 2016 21:20 UTC SaleCommon Stock 800 $96.18 $76,944.00
Disclosure

SEC source: 0001209191-16-093116 · doc4.xml · nonDerivative · entry 7

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 266,384

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F8 · price: Open market sales reported on this line occurred at a weighted average price of $96.18 (range $95.73 to $96.69).

Read SEC document
January 20, 2016 Filed Jan 22, 2016 21:20 UTC SaleCommon Stock 1,900 $95.24 $180,956.00
Disclosure

SEC source: 0001209191-16-093116 · doc4.xml · nonDerivative · entry 6

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 267,184

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F7 · price: Open market sales reported on this line occurred at a weighted average price of $95.24 (range $94.68 to $95.64).

Read SEC document
January 20, 2016 Filed Jan 22, 2016 21:20 UTC SaleCommon Stock 1,300 $93.71 $121,823.00
Disclosure

SEC source: 0001209191-16-093116 · doc4.xml · nonDerivative · entry 5

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 269,084

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F6 · price: Open market sales reported on this line occurred at a weighted average price of $93.71 (range $93.46 to $93.89).

Read SEC document
January 20, 2016 Filed Jan 22, 2016 21:20 UTC SaleCommon Stock 2,000 $92.87 $185,740.00
Disclosure

SEC source: 0001209191-16-093116 · doc4.xml · nonDerivative · entry 4

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 270,384

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F5 · price: Open market sales reported on this line occurred at a weighted average price of $92.87 (range $92.46 to $93.28).

Read SEC document
January 20, 2016 Filed Jan 22, 2016 21:20 UTC SaleCommon Stock 2,200 $91.87 $202,114.00
Disclosure

SEC source: 0001209191-16-093116 · doc4.xml · nonDerivative · entry 3

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 272,384

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F4 · price: Open market sales reported on this line occurred at a weighted average price of $91.87 (range $91.37 to $92.33).

Read SEC document
January 20, 2016 Filed Jan 22, 2016 21:20 UTC SaleCommon Stock 1,100 $90.46 $99,506.00
Disclosure

SEC source: 0001209191-16-093116 · doc4.xml · nonDerivative · entry 2

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 274,584

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F3 · price: Open market sales reported on this line occurred at a weighted average price of $90.46 (range $90.23 to $90.60).

Read SEC document
January 20, 2016 Filed Jan 22, 2016 21:20 UTC Exercise / conversionCommon Stock 10,400 $35.64 $370,656.00
Disclosure

SEC source: 0001209191-16-093116 · doc4.xml · nonDerivative · entry 1

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 275,684

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 13, 2016 Filed Jan 15, 2016 21:30 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 10,400 $0.00 Strike: $35.64 $0.00
Disclosure

SEC source: 0001209191-16-091731 · doc4.xml · derivative · entry 11

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,600

Underlying: Common Stock · 10,400 shares

Expires 2016-02-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F10 · derivative.exercise_date: Fully vested.

Read SEC document
January 13, 2016 Filed Jan 15, 2016 21:30 UTC SaleCommon Stock 400 $103.00 $41,200.00
Disclosure

SEC source: 0001209191-16-091731 · doc4.xml · nonDerivative · entry 8

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 265,284

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F9 · price: Open market sales reported on this line occurred at a weighted average price of $103.00 (range $103.00 to $103.01).

Read SEC document
January 13, 2016 Filed Jan 15, 2016 21:30 UTC SaleCommon Stock 400 $102.37 $40,948.00
Disclosure

SEC source: 0001209191-16-091731 · doc4.xml · nonDerivative · entry 7

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 265,684

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F8 · price: Open market sales reported on this line occurred at a weighted average price of $102.37 (range $101.67 to $102.61).

Read SEC document
January 13, 2016 Filed Jan 15, 2016 21:30 UTC SaleCommon Stock 1,600 $100.68 $161,088.00
Disclosure

SEC source: 0001209191-16-091731 · doc4.xml · nonDerivative · entry 6

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 266,084

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F7 · price: Open market sales reported on this line occurred at a weighted average price of $100.68 (range $100.37 to $101.23).

Read SEC document
January 13, 2016 Filed Jan 15, 2016 21:30 UTC SaleCommon Stock 600 $99.84 $59,904.00
Disclosure

SEC source: 0001209191-16-091731 · doc4.xml · nonDerivative · entry 5

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 267,684

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F6 · price: Open market sales reported on this line occurred at a weighted average price of $99.84 (range $99.22 to $100.18).

Read SEC document
January 13, 2016 Filed Jan 15, 2016 21:30 UTC SaleCommon Stock 2,300 $98.40 $226,320.00
Disclosure

SEC source: 0001209191-16-091731 · doc4.xml · nonDerivative · entry 4

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 268,284

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F5 · price: Open market sales reported on this line occurred at a weighted average price of $98.40 (range $98.05 to $98.86).

Read SEC document
January 13, 2016 Filed Jan 15, 2016 21:30 UTC SaleCommon Stock 2,300 $97.25 $223,675.00
Disclosure

SEC source: 0001209191-16-091731 · doc4.xml · nonDerivative · entry 3

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 270,584

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F4 · price: Open market sales reported on this line occurred at a weighted average price of $97.25 (range $96.95 to $97.81).

Read SEC document
January 13, 2016 Filed Jan 15, 2016 21:30 UTC SaleCommon Stock 2,800 $96.56 $270,368.00
Disclosure

SEC source: 0001209191-16-091731 · doc4.xml · nonDerivative · entry 2

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 272,884

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F3 · price: Open market sales reported on this line occurred at a weighted average price of $96.56 (range $95.94 to $96.93).

Read SEC document
January 13, 2016 Filed Jan 15, 2016 21:30 UTC Exercise / conversionCommon Stock 10,400 $35.64 $370,656.00
Disclosure

SEC source: 0001209191-16-091731 · doc4.xml · nonDerivative · entry 1

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 275,684

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 11, 2016 Filed Jan 15, 2016 02:22 UTC
LEIDEN JEFFREY MDirector · CEO & President
GiftStock Option (right to buy) · Derivative 110,625 $0.00 Strike: $45.11 $0.00
Disclosure

SEC source: 0001209191-16-091547 · doc4.xml · derivative · entry 4

LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President

10b5-1 filing: Not disclosed

Ownership: Indirect · Common Stock held in trust

Disclosed balance after: 110,625

Underlying: Common Stock · 110,625 shares

Expires 2023-02-04

F3 · derivative.exercise_date: The option vests in 16 quarterly installments from 2/5/2013.

F2 · balance_after: Gift of options held by Dr. Leiden to a grantor retained annuity trust for the benefit of his immediate family members. Dr. Leiden maintains beneficial ownership over the shares subject to the options.

Read SEC document
January 11, 2016 Filed Jan 15, 2016 02:22 UTC
LEIDEN JEFFREY MDirector · CEO & President
GiftStock Option (right to buy) · Derivative 110,625 $0.00 Strike: $45.11 $0.00
Disclosure

SEC source: 0001209191-16-091547 · doc4.xml · derivative · entry 3

LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,375

Underlying: Common Stock · 110,625 shares

Expires 2023-02-04

F3 · derivative.exercise_date: The option vests in 16 quarterly installments from 2/5/2013.

F2 · balance_after: Gift of options held by Dr. Leiden to a grantor retained annuity trust for the benefit of his immediate family members. Dr. Leiden maintains beneficial ownership over the shares subject to the options.

Read SEC document
January 11, 2016 Filed Jan 15, 2016 02:22 UTC
LEIDEN JEFFREY MDirector · CEO & President
GiftStock Option (right to buy) · Derivative 88,500 $0.00 Strike: $48.74 $0.00
Disclosure

SEC source: 0001209191-16-091547 · doc4.xml · derivative · entry 2

LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President

10b5-1 filing: Not disclosed

Ownership: Indirect · Common Stock held in trust

Disclosed balance after: 88,500

Underlying: Common Stock · 88,500 shares

Expires 2022-07-24

F1 · derivative.exercise_date: The option vests in 16 quarterly installments from 7/25/2012.

F2 · balance_after: Gift of options held by Dr. Leiden to a grantor retained annuity trust for the benefit of his immediate family members. Dr. Leiden maintains beneficial ownership over the shares subject to the options.

Read SEC document
January 11, 2016 Filed Jan 15, 2016 02:22 UTC
LEIDEN JEFFREY MDirector · CEO & President
GiftStock Option (right to buy) · Derivative 88,500 $0.00 Strike: $48.74 $0.00
Disclosure

SEC source: 0001209191-16-091547 · doc4.xml · derivative · entry 1

LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,500

Underlying: Common Stock · 88,500 shares

Expires 2022-07-24

F1 · derivative.exercise_date: The option vests in 16 quarterly installments from 7/25/2012.

F2 · balance_after: Gift of options held by Dr. Leiden to a grantor retained annuity trust for the benefit of his immediate family members. Dr. Leiden maintains beneficial ownership over the shares subject to the options.

Read SEC document
January 06, 2016 Filed Jan 8, 2016 21:03 UTC Exercise / conversionStock Option (right to buy) · Derivative 10,400 $0.00 Strike: $35.64 $0.00
Disclosure

SEC source: 0001209191-16-090512 · doc4.xml · derivative · entry 7

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,000

Underlying: Common Stock · 10,400 shares

Expires 2016-02-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: Fully vested.

Read SEC document
January 06, 2016 Filed Jan 8, 2016 21:03 UTC SaleCommon Stock 100 $123.02 $12,302.00
Disclosure

SEC source: 0001209191-16-090512 · doc4.xml · nonDerivative · entry 4

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 265,284

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

Read SEC document
January 06, 2016 Filed Jan 8, 2016 21:03 UTC SaleCommon Stock 6,905 $122.21 $843,860.05
Disclosure

SEC source: 0001209191-16-090512 · doc4.xml · nonDerivative · entry 3

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 265,384

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F4 · price: Open market sales reported on this line occurred at a weighted average price of $122.21 (range $121.95 to $122.69).

Read SEC document
January 06, 2016 Filed Jan 8, 2016 21:03 UTC SaleCommon Stock 3,395 $121.42 $412,220.90
Disclosure

SEC source: 0001209191-16-090512 · doc4.xml · nonDerivative · entry 2

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 272,289

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F3 · price: Open market sales reported on this line occurred at a weighted average price of $121.42 (range $120.94 to $121.93).

Read SEC document
January 06, 2016 Filed Jan 8, 2016 21:03 UTC Exercise / conversionCommon Stock 10,400 $35.64 $370,656.00
Disclosure

SEC source: 0001209191-16-090512 · doc4.xml · nonDerivative · entry 1

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 275,684

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 04, 2016 Filed Jan 6, 2016 22:03 UTC
Lee YuchunDirector
Exercise / conversionStock Option (right to buy) · Derivative 1,333 $0.00 Strike: $57.27 $0.00
Disclosure

SEC source: 0001209191-16-089929 · doc4.xml · derivative · entry 4

Lee Yuchun · CIK 0001334365 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,334

Underlying: Common Stock · 1,333 shares

Expires 2022-09-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The option vests in 16 quarterly installments from 09/14/2012.

Read SEC document
January 04, 2016 Filed Jan 6, 2016 22:03 UTC
Lee YuchunDirector
SaleCommon Stock 200 $122.87 $24,574.00
Disclosure

SEC source: 0001209191-16-089929 · doc4.xml · nonDerivative · entry 3

Lee Yuchun · CIK 0001334365 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,041

F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1.

F2 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F4 · price: Open market sales reported on this line occurred at a weighted average price of $122.87 (range $122.71 to $123.03).

Read SEC document
January 04, 2016 Filed Jan 6, 2016 22:03 UTC
Lee YuchunDirector
SaleCommon Stock 925 $122.07 $112,914.75
Disclosure

SEC source: 0001209191-16-089929 · doc4.xml · nonDerivative · entry 2

Lee Yuchun · CIK 0001334365 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,241

F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1.

F2 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F3 · price: Open market sales reported on this line occurred at a weighted average price of $122.07 (range $121.51 to $122.48).

Read SEC document
January 04, 2016 Filed Jan 6, 2016 22:03 UTC
Lee YuchunDirector
Exercise / conversionCommon Stock 1,333 $57.27 $76,340.91
Disclosure

SEC source: 0001209191-16-089929 · doc4.xml · nonDerivative · entry 1

Lee Yuchun · CIK 0001334365 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,166

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 04, 2016 Filed Jan 6, 2016 22:07 UTC GrantStock Option (right to buy) · Derivative 68,000 $0.00 Strike: $122.45 $0.00
Disclosure

SEC source: 0001209191-16-089945 · doc4.xml · derivative · entry 2

Parini Michael · CIK 0001661567 · EVP & CLO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,000

Underlying: Common Stock · 68,000 shares

Expires 2026-01-03

F2 · derivative.exercise_date: The option vests in 16 quarterly installments from 01/04/2016.

Read SEC document
January 04, 2016 Filed Jan 6, 2016 22:07 UTC GrantCommon Stock 13,800 $0.01 $138.00
Disclosure

SEC source: 0001209191-16-089945 · doc4.xml · nonDerivative · entry 1

Parini Michael · CIK 0001661567 · EVP & CLO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,800

F1 · shares: Stock grant under 2013 Stock and Option Plan, vesting in four annual installments from 01/04/2016.

Read SEC document
December 30, 2015 Filed Jan 4, 2016 21:03 UTC Exercise / conversionStock Option (right to buy) · Derivative 10,400 $0.00 Strike: $35.64 $0.00
Disclosure

SEC source: 0001209191-16-087741 · doc4.xml · derivative · entry 6

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,400

Underlying: Common Stock · 10,400 shares

Expires 2016-02-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: Fully vested.

Read SEC document
December 30, 2015 Filed Jan 4, 2016 21:03 UTC SaleCommon Stock 3,100 $127.55 $395,405.00
Disclosure

SEC source: 0001209191-16-087741 · doc4.xml · nonDerivative · entry 3

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 265,284

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F4 · price: Open market sales reported on this line occurred at a weighted average price of $127.55 (range $127.38 to $127.83).

Read SEC document
December 30, 2015 Filed Jan 4, 2016 21:03 UTC SaleCommon Stock 7,300 $126.98 $926,954.00
Disclosure

SEC source: 0001209191-16-087741 · doc4.xml · nonDerivative · entry 2

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 268,384

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F3 · price: Open market sales reported on this line occurred at a weighted average price of $126.98 (range $126.38 to $127.37).

Read SEC document
December 30, 2015 Filed Jan 4, 2016 21:03 UTC Exercise / conversionCommon Stock 10,400 $35.64 $370,656.00
Disclosure

SEC source: 0001209191-16-087741 · doc4.xml · nonDerivative · entry 1

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 275,684

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 21, 2015 Filed Dec 22, 2015 15:11 UTC Exercise / conversionStock Option (right to buy) · Derivative 10,400 $0.00 Strike: $35.64 $0.00
Disclosure

SEC source: 0001209191-15-086507 · doc4.xml · derivative · entry 8

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,800

Underlying: Common Stock · 10,400 shares

Expires 2016-02-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: Fully vested.

Read SEC document
December 21, 2015 Filed Dec 22, 2015 15:11 UTC SaleCommon Stock 600 $120.65 $72,390.00
Disclosure

SEC source: 0001209191-15-086507 · doc4.xml · nonDerivative · entry 5

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 265,284

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F6 · price: Open market sales reported on this line occurred at a weighted average price of $120.65 (range $120.56 to $120.67).

Read SEC document
December 21, 2015 Filed Dec 22, 2015 15:11 UTC SaleCommon Stock 4,100 $120.07 $492,287.00
Disclosure

SEC source: 0001209191-15-086507 · doc4.xml · nonDerivative · entry 4

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 265,884

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F5 · price: Open market sales reported on this line occurred at a weighted average price of $120.07 (range $119.50 to $120.46).

Read SEC document
December 21, 2015 Filed Dec 22, 2015 15:11 UTC SaleCommon Stock 3,400 $118.94 $404,396.00
Disclosure

SEC source: 0001209191-15-086507 · doc4.xml · nonDerivative · entry 3

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 269,984

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F4 · price: Open market sales reported on this line occurred at a weighted average price of $118.94 (range $118.44 to $119.34).

Read SEC document
December 21, 2015 Filed Dec 22, 2015 15:11 UTC SaleCommon Stock 2,300 $117.93 $271,239.00
Disclosure

SEC source: 0001209191-15-086507 · doc4.xml · nonDerivative · entry 2

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 273,384

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F3 · price: Open market sales reported on this line occurred at a weighted average price of $117.93 (range $117.42 to $118.37).

Read SEC document
December 21, 2015 Filed Dec 22, 2015 15:11 UTC Exercise / conversionCommon Stock 10,400 $35.64 $370,656.00
Disclosure

SEC source: 0001209191-15-086507 · doc4.xml · nonDerivative · entry 1

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 275,684

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 16, 2015 Filed Dec 18, 2015 22:22 UTC Exercise / conversionStock Option (right to buy) · Derivative 10,400 $0.00 Strike: $35.64 $0.00
Disclosure

SEC source: 0001209191-15-086152 · doc4.xml · derivative · entry 9

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,200

Underlying: Common Stock · 10,400 shares

Expires 2016-02-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_date: Fully vested.

Read SEC document
December 16, 2015 Filed Dec 18, 2015 22:22 UTC SaleCommon Stock 1,000 $118.81 $118,810.00
Disclosure

SEC source: 0001209191-15-086152 · doc4.xml · nonDerivative · entry 6

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 265,284

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F7 · price: Open market sales reported on this line occurred at a weighted average price of $118.81 (range $118.52 to $119.21).

Read SEC document
December 16, 2015 Filed Dec 18, 2015 22:22 UTC SaleCommon Stock 400 $117.73 $47,092.00
Disclosure

SEC source: 0001209191-15-086152 · doc4.xml · nonDerivative · entry 5

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 266,284

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F6 · price: Open market sales reported on this line occurred at a weighted average price of $117.73 (range $117.42 to $117.92).

Read SEC document
December 16, 2015 Filed Dec 18, 2015 22:22 UTC SaleCommon Stock 4,400 $116.47 $512,468.00
Disclosure

SEC source: 0001209191-15-086152 · doc4.xml · nonDerivative · entry 4

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 266,684

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F5 · price: Open market sales reported on this line occurred at a weighted average price of $116.47 (range $116.21 to $117.15).

Read SEC document
December 16, 2015 Filed Dec 18, 2015 22:22 UTC SaleCommon Stock 2,600 $115.72 $300,872.00
Disclosure

SEC source: 0001209191-15-086152 · doc4.xml · nonDerivative · entry 3

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 271,084

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F4 · price: Open market sales reported on this line occurred at a weighted average price of $115.72 (range $115.20 to $116.04).

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.